Mark Boyagi, P.C.

Kirkland & Ellis advised private equity and credit firm Abry Partners on the closing of a $1.6 billion GP-led transaction to create a continuation vehicle for Abry Advanced Securities Fund III. The transaction was announced August 29, 2024. Read the transaction press release The Kirkland team was led by investment funds partners Mark Boyagi, Adam Aramati, Garrett Lorentz and David Sherman and associates Davi Sacco and Kasondra West; corporate partners Dan Vaczy and Amanda Border; derivatives partner Scott Gordon; tax partners Alec Campbell and Brandon Short; and debt finance partners Jocelyn Hirsch, Ashley Gregory and Leonard Kim.

Aug 30

1 min

Kirkland & Ellis is advising technology investor Silver Lake on the $13 billion acquisition of global sports and entertainment company Endeavor Group Holdings, Inc. (NYSE: EDR). The transaction was announced April 2, 2024. According to the definitive agreement, Silver Lake will pay Endeavor shareholders $27.50 per share in cash, representing a 55% premium to the unaffected share price of $17.72 per share at market close on October 25, 2023, the last full trading day prior to Endeavor’s announcement of its review of strategic alternatives. The price puts an equity value of $13 billion on Endeavor with a combined enterprise value of over $25 billion when consolidating TKO’s value into Endeavor. Silver Lake previously supported Endeavor’s acquisition of UFC in 2016 and the merger of UFC and WWE, creating TKO (NYSE: TKO) in 2023. TKO is not party to the transaction and will remain publicly traded.  The transaction is expected to close by the end of the first quarter of 2025, pending customary closing conditions and regulatory approval. Read the transaction's press release The Kirkland team is being led by investment funds partners Mark Boyagi, Jordan Murray, Eric Fischer, Kevin Lam and Leslie Hung and tax partners Lee Morlock and Joseph Tootle.

Apr 3

1 min

Kirkland & Ellis advised Eldridge on the closing of a transaction where Eldridge’s inaugural diversified credit platform fund acquired a portfolio of loans and leases from Eldridge and its affiliates, that is expected to provide up to approximately $1.5 billion in investable capital. The transaction was capitalized with equity commitments anchored by Carlyle AlpInvest and its co-investors and a new asset-backed credit facility. The transaction closed on January 14, 2026. Read the transaction press release The Kirkland team included investment funds lawyers Mark Boyagi, Társis Gonçalves, Susan Burkhardt, Jake Heyka, Ethan Green, Bryon Boyce, Chris Marano and Eric Duncan; trusts & estates lawyer Thomas Norelli; tax lawyers Elie Zolty, Andrew Chan and Lisa Chen; investment funds regulatory lawyers Nabil Sabki and Jasmina Resic; and debt finance lawyers Stewart Ross and Sean Sullivan.

Jan 22

1 min

Kirkland & Ellis represented HarbourVest Partners, LLC, as the sole lead investor in Aquiline Capital Partners LP’s $1.1 billion multi-asset continuation fund, Aquiline Financial Services Continuation Fund LP. Aquiline Capital Partners LP is a private investment firm dedicated to financial services and related technologies. The continuation fund was established to acquire select portfolio companies across both Aquiline Financial Services Fund II LP and Aquiline Financial Services Fund III LP. A meaningful portion of the new continuation fund will be available as follow-on capital to support future growth initiatives and potential strategic acquisitions within the portfolio. Read the transaction press release The Kirkland team was led by investment funds partners Tarsis Goncalves and Mark Boyagi and associates Tahanna Byatt and Casey Bond; and tax partner Alec Campbell and associate Margot Solmssen.

Jun 6

1 min

Kirkland & Ellis advised Patient Square Capital (Patient Square), a leading health care investment firm, on the formation of its inaugural fund, Patient Square Equity Partners (PSEP), with approximately $3.9 billion in total committed capital as of its final closing. PSEP surpassed its $3 billion target and is both the largest first-time private equity fund ever raised and the largest fund ever raised by a dedicated health-care-focused private equity, growth equity or venture capital firm. At the final close, Patient Square’s total assets under management (AUM) stood at approximately $5.9 billion, including significant co-investment commitments from leading institutional investors. Patient Square invests broadly across the health care industry, including development-stage therapeutics; commercial-stage pharmaceuticals; medical devices, diagnostics and life science tools; health care providers; and technology-enabled and other services. Commitments to PSEP were secured from a diverse and global set of institutional investors, including leading sovereign wealth funds, pension funds, endowments, foundations, family offices, hospital systems, consultants, private wealth platforms and insurance companies. The final closing of PSEP was announced on February 1, 2023. Read Patient Square’s press release The Kirkland team was led by investment funds partners Daniel Lavon-Krein, Paul Watt and Barry Le Vine, and included investment funds partners Mark Boyagi and Amanda Strickler, with assistance from associates Jackie Ting, Nathan Calko, Alex Burt, Wilford Ng, Bojun Xu, Cynthia Situ, Alicia Nakhjavan and Devon Salge; investment funds regulatory partners Alpa Patel, Lisa Cawley and Zach Milloy and associates Nick D’Ambrosio, Radhika Kshatriya and Jade Bernard; tax partners Lee Morlock, Joel Peters-Fransen and associate Allison Bray; debt finance partner Aditi Iyer and associates Adnan Hussain and Alex Straka; investment funds ERISA partner Sabrina Glaser; and ESG & impact partner Alex Farmer and associates Emilie Jones and Donna Ni. The Patient Square team also includes restructuring partner Edward Sassower; corporate partners Michael Weisser, Ryan Brissette and Maggie Flores; debt finance partner Jason Kanner; and tax partner Mark Schwed.

Feb 1

1 min